Tumor Volume Doubling Time as a Dynamic Prognostic Marker for Patients with Hepatocellular Carcinoma.

about

Tumor Volume Doubling Time as a Dynamic Prognostic Marker for Patients with Hepatocellular Carcinoma.

Item

http://www.wikidata.org/entity/Q50501948

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Tumor Volume Doubling Time as ...... with Hepatocellular Carcinoma.

@en

Tumor Volume Doubling Time as ...... with Hepatocellular Carcinoma.

@nl

type

Item

label

Tumor Volume Doubling Time as ...... with Hepatocellular Carcinoma.

@en

Tumor Volume Doubling Time as ...... with Hepatocellular Carcinoma.

@nl

prefLabel

Tumor Volume Doubling Time as ...... with Hepatocellular Carcinoma.

@en

Tumor Volume Doubling Time as ...... with Hepatocellular Carcinoma.

@nl

P1476

Tumor Volume Doubling Time as ...... with Hepatocellular Carcinoma

@en

P2093

Danbi Lee

http://www.w3.org/2001/XMLSchema#string

Han Chu Lee

http://www.w3.org/2001/XMLSchema#string

Hyung-Don Kim

http://www.w3.org/2001/XMLSchema#string

Jong Kwan Kim

http://www.w3.org/2001/XMLSchema#string

Kang Mo Kim

http://www.w3.org/2001/XMLSchema#string

Mi-Jung Jun

http://www.w3.org/2001/XMLSchema#string

Sung-Cheol Yun

http://www.w3.org/2001/XMLSchema#string

Young-Hwa Chung

http://www.w3.org/2001/XMLSchema#string

Young-Suk Lim

http://www.w3.org/2001/XMLSchema#string

Yung Sang Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Management of hepatocellular carcinoma: An update

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

A biomathematical approach to clinical tumor growth.

Evaluation of the prognosis for small hepatocellular carcinoma based on tumor volume doubling time. A preliminary report.

V-CLIP: Integrating plasma vascular endothelial growth factor into a new scoring system to stratify patients with advanced hepatocellular carcinoma for clinical trials.

I-CLIP: improved stratification of advanced hepatocellular carcinoma patients by integrating plasma IGF-1 into CLIP score.

Surgical Strategy for Hepatocellular Carcinoma Patients with Portal/Hepatic Vein Tumor Thrombosis

Growth rate of early-stage hepatocellular carcinoma in patients with chronic liver disease

Tumor growth rate and prognosis of breast cancer mainly detected by mass screening.

P2888

s10620-017-4708-6

P304

2923-2931

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10620-017-4708-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ju Hyun Shim

Jihyun An

P577

2017-08-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28815349

http://www.w3.org/2001/XMLSchema#string